Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents.

@article{Meade2012PrimaryPO,
  title={Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents.},
  author={Tom W Meade},
  journal={Handbook of experimental pharmacology},
  year={2012},
  volume={210},
  pages={
          565-605
        }
}
  • Tom W Meade
  • Published in
    Handbook of experimental…
    2012
  • Medicine
  • In those who have already survived myocardial infarction (MI) or stroke, or have had a transient ischaemic episode (TIA), daily low dose aspirin (ASA) reduces the risk of recurrences by an amount that greatly exceeds the risk of serious bleeding (secondary prevention). ASA is therefore recommended for these people. However, in primary prevention-reducing risk in those so far free of clinically manifest episodes-the benefit is of the same order as the bleeding hazard, (which is much the same in… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv